Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus I Infection”

333 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 333 results

Testing effectiveness (Phase 2)UnknownNCT06282783
What this trial is testing

Studying Topiramate for Re-Activating the HIV-1 Reservoir

Who this might be right for
HIV-1-infectionHivHIV Infections+1 more
Erasmus Medical Center 12
Not applicableUnknownNCT05071378
What this trial is testing

Leveraging Family-Based Assets for Black MSM In House Ball Communities

Who this might be right for
HIV I Infection
State University of New York - Downstate Medical Center 168
Early research (Phase 1)Study completedNCT03149848
What this trial is testing

Effect of Rifabutin on the Pharmacokinetics of Oral Cabotegravir in Healthy Subjects

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 15
Early research (Phase 1)Study completedNCT01289951
What this trial is testing

Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis

Who this might be right for
Human Immunodeficiency VirusHepatitis C
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 10
Not applicableLooking for participantsNCT06834113
What this trial is testing

Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality Headset

Who this might be right for
HIV I InfectionInjection Pain
Centre Hospitalier Régional d'Orléans 120
Early research (Phase 1)Study completedNCT02388594
What this trial is testing

A Phase I Study of T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728mR in HIV-Infected Patients

Who this might be right for
Human Immunodeficiency Virus (HIV)
University of Pennsylvania 14
Early research (Phase 1)Study completedNCT01519128
What this trial is testing

Investigate the Effect of Steady-State TMC278 on the Pharmacokinetics of a Single Dose of Digoxin

Who this might be right for
Healthy
Janssen R&D Ireland 22
Early research (Phase 1)Ended earlyNCT00006153
What this trial is testing

Effectiveness of Adding Remune to Your Current Anti-HIV Drug Combination

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 45
Early research (Phase 1)Study completedNCT01822522
What this trial is testing

Cabozantinib S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus

Who this might be right for
Advanced Malignant Solid NeoplasmHIV InfectionMetastatic Malignant Solid Neoplasm+2 more
National Cancer Institute (NCI) 36
Not applicableWithdrawnNCT01692470
What this trial is testing

A Study on the Safety and Effectiveness of Rilpivirine Hydrochloride (Edurant) Among Adult Filipino Patients With Human Immunodeficiency Virus Type-I Infection

Who this might be right for
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Janssen Pharmaceutica
Testing effectiveness (Phase 2)Study completedNCT03008941
What this trial is testing

Microbiota Restoration Therapy in HIV With Repeated Low-Dose Interventions

Who this might be right for
HIV Infection
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 30
Testing effectiveness (Phase 2)Ended earlyNCT00104429
What this trial is testing

GW873140 In Combination With Combivir In HIV Infected Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 125
Early research (Phase 1)Study completedNCT00002214
What this trial is testing

Phase I Trial of S-1153 in Patients With HIV Infection

Who this might be right for
HIV Infections
Lexigen Pharmaceuticals 40
Early research (Phase 1)Study completedNCT02066428
What this trial is testing

A Phase I Randomized Placebo-Controlled, Double-Blind Study to Evaluate Safety and Immunogenicity of AERAS-404 Administered as Different Amounts of Antigen and Adjuvant Combinations in HIV-Negative BCG-Vaccinated Adults Without Evidence of Tuberculosis Infection

Who this might be right for
Tuberculosis
Aeras 64
Early research (Phase 1)Study completedNCT00000972
What this trial is testing

A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. The Safety and Immunogenicity of Env 2-3, a Yeast Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 64
Early research (Phase 1)Study completedNCT02373930
What this trial is testing

Relative Oral Bioavailability Study of Different Fixed Dose Combinations of Dolutegravir and Rilpivirine in Healthy Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 63
Testing effectiveness (Phase 2)Study completedNCT02471430
What this trial is testing

Reducing the Residual Reservoir of HIV-1 Infected Cells in Patients Receiving Antiretroviral Therapy

Who this might be right for
HIV Infection
Massachusetts General Hospital 17
Testing effectiveness (Phase 2)Study completedNCT02457689
What this trial is testing

The Safety and Immunogenicity of the DNA-GTU Vaccine Administered to HIV-infected Patients on ART vs Placebo

Who this might be right for
HIV
Imperial College London 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07124559
What this trial is testing

Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV

Who this might be right for
Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 144
Testing effectiveness (Phase 2)Study completedNCT02766049
What this trial is testing

Study of Anti-HIV Cellular Therapy Based on Dendritic Cells Pulsed With Chemically Inactivated Virus

Who this might be right for
HIV Infection
University of Sao Paulo General Hospital 19
Load More Results